Related Experiment Video
Updated: Jul 1, 2025
03:13
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
2.2K
RNA therapeutics for kidney injury
Pouya Goleij1, Pantea Majma Sanaye2, Aryan Rezaee3
1Department of Genetics, Sana Institute of Higher Education, Sari, Iran; USERN Office, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Progress in Molecular Biology and Translational Science
|March 8, 2024
Summary
RNA therapy offers a promising approach to treating kidney diseases by targeting specific cellular pathways. Nanotechnology integration enhances the delivery of these RNA-based drugs for improved therapeutic outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- RNA therapy utilizes RNA molecules to modulate biological pathways for disease treatment.
- Expanding knowledge of RNA functions broadens its therapeutic applications.
- Kidney diseases present a significant target for RNA-based interventions.
Approach:
- This review explores the therapeutic potential of RNA-based therapies for various kidney conditions.
- Specific genes and pathways involved in kidney disease (inflammation, fibrosis, oxidative stress) are targeted.
- The role of specific kidney cells in RNA therapy is examined.
Key Points:
- RNA therapies show promise for treating kidney infections, inflammation, nephrotoxicity, and ischemia/reperfusion injury.
- Nanotechnology and ligand-targeted RNA vehicles are being developed to overcome delivery challenges.
- Efficient delivery systems are crucial for maximizing the impact of RNA-based drugs.
Conclusions:
- RNA-based therapies represent a novel and evolving strategy for kidney disease management.
- Targeted delivery systems are essential for the clinical success of RNA therapeutics in nephrology.
- Further research into RNA mechanisms and delivery is vital for advancing kidney disease treatment.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
625
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
625
01:10Nephrons
2.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.4K
01:22Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375